Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14921-14926
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14921
Table 1 Comparison of different treatment options
Treatment optionCases (n)Death (n)Perioperative death rate
Non-surgical treatment10770.00%
TAE16318.80%
Surgical treatment
Hepatic artery ligation4125.00%
Suture hemostasis11436.40%
Hepatic resection19210.50%
Summary601728.30%
Table 2 Univariate analysis of the risk factors of mortality after liver resection n (%)
IndexesMortality
P value
YesNo
Gender
Male6 (85.7)24 (88.9)NS
Female1 (14.3)3 (11.2)NS
Age (yr)56.2 ± 7.252.8 ± 6.1NS
Shock7 (100)17 (62.3)0.041
Liver cirrhosis (n)7 (100)25 (92.3)NS
Tumour diameter (cm)12.4 ± 3.610.7 ± 4.4NS
Child grade
A013 (48.1)NS
B4 (57.1)12 (44.4)NS
C3 (42.3)2 (7.4)0.005
Blood transfusion210012000.037
Total bilirubin61.1 ± 12.522.3 ± 8.90.024
Plasma-albumin35.3 ± 4.436.3 ± 4.6NS
Portal vein tumor-thrombosis2 (28.6)5 (18.5)NS
Ascites
Yes1 (14.3)2 (7.4)NS
No6 (85.6)25 (92.6)NS
AFP11750 ± 34606771 ± 2430NS
ALT143 ± 26127 ± 36NS
PT (INR)12.7 ± 1.311.8 ± 0.9NS
Table 3 Univariate analysis of the risk factors of mortality after transcatheter arterial embolization n (%)
IndexesMortality
P value
YesNo
Gender
Male39NS
Female04
Age (yr)63.1 ± 4.360.4 ± 7.7NS
Shock3 (100)8 (61.5)0.044
Liver cirrhosis313NS
Tumor diameter13.2 ± 3.49.1 ± 4.40.047
Child grade
A
B19NS
C2 (66.7)4 (30.8)0.007
Blood transfusion14008000.036
Total bilirubin50.2 ± 7.544.3 ± 10.1NS
Plasma-albumin33.2.3 ± 3.735.4 ± 5.1NS
Portal vein tumor-thrombosis2 (66.7)4 (30.8)NS
Ascites
Yes1 (33.3)5 (38.5)NS
No29NS
AFP12334 ± 236510776 ± 4472NS
ALT276 ± 55187 ± 43NS
PT (INR)17.2 ± 3.114.8 ± 4.2NS